Liu Xiao-Hui, Du Yu-Min, Cong Hai-Jing, Liu Guang-Zhao, Ren Yu-E
Department of Pain Management, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Front Neurol. 2021 Jan 13;11:564643. doi: 10.3389/fneur.2020.564643. eCollection 2020.
To study the effects of continuous epidural injection of dexamethasone on blood glucose, blood lipids, plasma cortisol, and adrenocorticotropic hormone (ACTH) in patients with neuropathic pain. Thirty patients with cervical spondylotic radiculopathy, lumbar disc herniation, herpes pain or postherpetic neuralgia were randomly divided into three groups and were treated with different doses of epidural injection of dexamethasone (Group S with a concentration of 25 μg/mL; Group M with a concentration of 50 μg/mL; Group L with a concentration of 100 μg/mL). Epidural catheterization placement was guided by computed tomography (CT), and was connected to the analgesic pump for 10 days. Visual Analog Score (VAS), fasting blood glucose (FBG), total cholesterol (CHOL), triglyceride (TG), 2 h postprandial blood glucose (2hPG) and the concentrations of cortisol, ACTH were measured before injection (T), 2, 4, 6, 8, and 10 days during injection (D, D, D, D, D), and 7, 14, 21, 28 days (W, W, W, W) after injection. During and after the treatment, VAS score was significantly decreased, and group M and L had the lowest VAS score. The concentrations of cortisol and ACTH were significantly lower during the treatment, but all of them recovered to the normal level after stopping the injection. The treatment did not affect the CHOL and TG concentrations. Epidural injection of dexamethasone at the concentration of 50 μg/mL is recommended for patients with neuropathic pain because of its good analgesic effect and less adverse effect on blood glucose, plasma cortisol, and ACTH.
研究连续硬膜外注射地塞米松对神经性疼痛患者血糖、血脂、血浆皮质醇和促肾上腺皮质激素(ACTH)的影响。将30例患有神经根型颈椎病、腰椎间盘突出症、疱疹疼痛或带状疱疹后神经痛的患者随机分为三组,分别接受不同剂量的硬膜外地塞米松注射治疗(S组浓度为25μg/mL;M组浓度为50μg/mL;L组浓度为100μg/mL)。硬膜外导管置入在计算机断层扫描(CT)引导下进行,并连接镇痛泵持续10天。分别在注射前(T)、注射期间的第2、4、6、8和10天(D1、D2、D3、D4、D5)以及注射后第7、14、21、28天(W1、W2、W3、W4)测量视觉模拟评分(VAS)、空腹血糖(FBG)、总胆固醇(CHOL)、甘油三酯(TG)、餐后2小时血糖(2hPG)以及皮质醇、ACTH的浓度。治疗期间及治疗后,VAS评分显著降低,M组和L组的VAS评分最低。治疗期间皮质醇和ACTH浓度显著降低,但停药后均恢复至正常水平。该治疗对CHOL和TG浓度无影响。对于神经性疼痛患者,推荐使用浓度为50μg/mL的地塞米松进行硬膜外注射,因其镇痛效果良好且对血糖、血浆皮质醇和ACTH的不良反应较少。